December 15th, 2015

Biogen Idec Inc. (NASDAQ:BIIB) | Better Buy: Biogen or Amgen?

[at Motley Fool] – Both Biogen and Amgen are fighting competition with new drugs with blockbuster potential, but is one a better buy than the other? Read more on this. Biogen Idec . . . → Read More: Biogen Idec Inc. (NASDAQ:BIIB) | Better Buy: Biogen or Amgen? Similar posts: Company Update – Amgen Inc. (NASDAQ:AMGN) – Better Buy: Biogen or Amgen? Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies

Biogen Idec Inc. (NASDAQ:BIIB) [at Motley Fool] – Both Biogen and Amgen are fighting competition with new drugs with blockbuster potential, but is one a better buy than the other?
Read more on this.

Biogen Idec Inc. (BIIB), with a current value of $56.39B, started the … [visit site to read more]

Similar posts:
  1. Company Update – Amgen Inc. (NASDAQ:AMGN) – Better Buy: Biogen or Amgen?
  2. Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading
  3. Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.